Results 101 to 110 of about 87,119 (289)

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants

European Journal of Haematology, EarlyView.
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto, Silvia Sorella, Erminia Baldacci, Massimo Breccia, Sabina Chiaretti, Marcello Capriata, Livia Donzelli, Gianna Maria D'Elia, Salvatore Giacomo Morano, Ilaria Del Giudice, Maurizio Martelli, Cristina Santoro, Antonio Chistolini   +12 more
wiley   +1 more source

Neutrophilic leukocytosis in advanced stage polycythemia vera : hematopathologic features and prognostic implications

, 2015
Polycythemia vera in 20-30% of cases progresses towards post-polycythemic myelofibrosis, an advanced phase characterized by decreased red blood cells counts and increasing splenomegaly with extramedullary hematopoiesis.
I. Bonzheim, D. Cattaneo, D. Knowles, A. Iurlo, F. Fend, L. Boiocchi, A. Orazi, U. Gianelli   +7 more
core   +1 more source

Effective treatment of advanced lung adenocarcinoma with paraneoplastic leukemoid reaction with Lorlatinib: a case report

Frontiers in Oncology
BackgroundLorlatinib is a new generation ALK kinase inhibitor. We describe a 52-year-old patient with ALK-positive advanced lung adenocarcinoma who achieved remission after multi-line therapy combined with paraneoplastic leukemoid reaction treated with ...
Ruiqi Niu, Yiruo Zhang, Jingdan Pang, Qing Zhou, Yu Lei, Yingying Du   +5 more
doaj   +1 more source

Feasibility and Safety of Venetoclax for Cytoreduction During Induction Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

European Journal of Haematology, EarlyView.
ABSTRACT Objective This study aimed to evaluate the feasibility and safety of venetoclax as a cytoreductive strategy during induction therapy in newly diagnosed acute promyelocytic leukemia (APL), and to provide an exploratory description of its early efficacy.
Yu Wang, Rong Xiao, Xiaobing Huang, Yi Xiao   +3 more
wiley   +1 more source

Leukocytosis in the critically ill patient

, 2014
The occurrence of leukocytosis is common in critically ill patients, and in most cases it can be ascribed to an underlying infection and/or sepsis. However, in many cases the clinical presentation of the white blood cell count can be misleading, and ...
AGBEDJRO, ANTOINETTE, Giorgio Berlot, PRESELLO, BARBARA, Antoinette Agbedyro, BERLOT, GIORGIO, Barbara Presello   +5 more
core   +1 more source

The incidence and risk factors of intraoperative bacterial contamination in primary total knee arthroplasty

Frontiers in Surgery
BackgroundInfection is a devasting complication after arthroplasty. Identifying potential sources contributing to intraoperative bacterial transmission can help to reduce surgical-site infections.ObjectiveThe aim of this study was to identify the ...
Lijun Xing, Fengyue Liu, Enrun Li, Yuling Kang, Kunyuan Tan, Juhong Li   +5 more
doaj   +1 more source

Treatment Patterns, Outcomes and Survival Trends in T‐Cell Prolymphocytic Leukemia: A Nationwide Population‐Based Study in the Netherlands

European Journal of Haematology, EarlyView.
ABSTRACT Background T‐cell prolymphocytic leukemia (T‐PLL) is a rare, aggressive mature T‐cell malignancy with limited therapeutic options. Alemtuzumab remains the backbone of therapy, and fit responders are consolidated with allogeneic stem cell transplantation (alloSCT). However, contemporary population‐level outcomes remain poorly defined.
Mirian Brink, Arie C. van der Spek, Jeanette K. Doorduijn, Koen de Heer, Sabina Kersting, Lidwine W. Tick, Doreen G. te Raa, Hanneke M. van der Straaten, Gerrit Jan Veldhuis, Laurens Laterveer, Rogier Mous, Mark‐David Levin, Kees Meijer, Andre Mulder, M. Nijland, Gerwin Huls, Arnon P. Kater, Mar Bellido   +17 more
wiley   +1 more source

Recurrent pericarditis: a case report and literature review

Acta Medica Lituanica, 2017
Background. Recurrence affects about 30% (20% to 50%) of patients within 18 months after the initial episode of acute pericarditis resulting in subsequent rehospitalizations.
Justina Katinaitė, Birutė Petrauskienė   +1 more
doaj   +1 more source

ICSH Guidance on Bone Marrow Examination and Reporting

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Examination of the bone marrow (BM) remains fundamental to the diagnosis, classification, prognostication, and monitoring of hematolymphoid and other disorders affecting blood cell production. Since publication of the International Council for Standardization in Haematology (ICSH) guideline in 2008, advances in diagnostic technologies, disease
Wendy N. Erber, Alexandar Tzankov, Olga Pozdnyakova, Hiromichi Matsushita, Gina Zini, Leonie Saft, on behalf of the International Council for Standardization in Haematology   +6 more
wiley   +1 more source

Evaluation of effects of Bauhinia variegata stem bark extracts against milk-induced eosinophilia in mice

Journal of Advanced Pharmaceutical Technology & Research, 2011
Bauhinia variegata Linn (family: Caesalpiniaceae), popularly known as Rakta Kanchnar, is a medium-sized tree found throughout India. The stem bark of B. variegata (BV) is used traditionally in the treatment of asthma, jaundice, tuberculosis, leprosy, and
Ravindra G Mali, Avinash S Dhake
doaj   +1 more source